PAUL LING to Epstein-Barr Virus Infections
This is a "connection" page, showing publications PAUL LING has written about Epstein-Barr Virus Infections.
Connection Strength
1.431
-
EBNA2 and Its Coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015; 391:35-59.
Score: 0.389
-
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
Score: 0.313
-
Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function. J Virol. 2009 Jul; 83(14):7109-16.
Score: 0.262
-
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003 Nov 01; 37(9):1244-9.
Score: 0.178
-
Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003 Jun; 77(11):6546-50.
Score: 0.174
-
Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon. J Interferon Cytokine Res. 2008 Nov; 28(11):667-78.
Score: 0.063
-
Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol. 2002 Jul; 67(3):320-6.
Score: 0.041
-
Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002 Jan 15; 168(2):909-18.
Score: 0.010